| Daiichi Sankyo (Schweiz) AG - VANFLYTA 17.7 mg, Filmtabletten | | 69710 | | 01 | | VANFLYTA 17.7 mg | | Filmtabletten | | L01EX11 | | Quizartinib | | 31.03.2025 | | |
| | Composition | | quizartinibi dihydrochloridum 20 mg corresp. quizartinibum 17.7 mg, hydroxypropylbetadexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, talcum, triacetinum, E 171, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Quizartinibi Dihydrochloridum | 20 mg correspond Quizartinibum 17.7 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylbetadexum | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 14 | DDP | DDP | A | | Non | | 002 | 28 | DDP | DDP | A | | Non |
|
|
